Baolingbao Biology Co.,Ltd. (SHE:002286)

China · Delayed Price · Currency is CNY

8.54

+0.03 (0.35%)

Oct 14, 2026, 1:35 PM CST

Market Cap	3.25B -13.6%
Revenue (ttm)	2.85B +8.9%
Net Income	140.28M +4.3%
EPS	0.38 +5.5%
Shares Out	379.98M
PE Ratio	22.47
Forward PE	16.11
Dividend	0.12 (1.41%)
Ex-Dividend Date	Oct 14, 2026

Volume	22,751,459
Open	8.35
Previous Close	8.51
Day's Range	8.21 - 8.86
52-Week Range	7.15 - 11.69
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of functional sugar in China and internationally. The company offers prebiotics, including galacto-oligosaccharides, isomaltooligosaccharides, fructooligosaccharides, and xylooligosaccharides; sugar alcohols and sources, such as erythritol, trehalose, crystallized fructose, allulose, and maltotetrasaccharide; dietary fiber comprising polydextrose and resistant dextrin; modified, waxy corn, and corn starch products; starch s... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1997

Employees 1,505

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002286

Full Company Profile

Financial Performance

In 2025, Baolingbao Biology's revenue was 2.75 billion, an increase of 14.54% compared to the previous year's 2.40 billion. Earnings were 150.63 million, an increase of 35.50%.

Financial Statements